•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Boston Scientific Corporation (NYSE: BSX) will release earnings for its first quarter before the opening bell on Wednesday, April 22. Analysts expect the Marlborough, Massachusetts-based company to report quarterly earnings of 79 cents per share, up from 75 cents per share in the year-ago period. The consensus estimate for Boston Scientific’s quarterly revenue is $5.17 billion, compared with $4.66 billion reported last year, according to Benzinga Pro.
On March 28, Boston Scientific announced data from its HI-PEITHO clinical trial evaluating the EKOS Endovascular System in patients with pulmonary embolism.
Shares of Boston Scientific fell 2.4% to close at $59.52 on Tuesday.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
